Consensus guidelines for the use of concurrent TMS-fMRI in cognitive and clinical neuroscience
- PMID: 40555803
- DOI: 10.1038/s41596-025-01182-4
Consensus guidelines for the use of concurrent TMS-fMRI in cognitive and clinical neuroscience
Abstract
Concurrent transcranial magnetic stimulation (TMS) and functional magnetic resonance imaging (TMS-fMRI) provides a step-change in the toolkit of neuroscience research. TMS enables the noninvasive perturbation of ongoing human brain activity, and when coupled to fMRI for the simultaneous read-out of its effects across the brain, concurrent TMS-fMRI enables studies aimed at determining the causal inference of human brain-behavior relationships, with implications for both fundamental research and clinical application. Many of the technical barriers to TMS-fMRI implementation, such as hardware design and setups, have now been overcome, and the research community in the field is rapidly growing. Here, we present the guidelines set by an international consensus, from researchers at all levels and across the fields of cognitive and applied human neuroscience, for the experimental design and practical considerations of concurrent TMS-fMRI via 12 detailed use cases. These guidelines may facilitate the uptake of this approach and simplify the experimental design and planning stages.
© 2025. Springer Nature Limited.
Conflict of interest statement
Competing interests: A.T.S. is Chief Scientific Advisor of PlatoScience Medical and Alpha Brain Technologies, Chief Executive Officer of Neurowear Medical and Director of the Clinical TMS Certification Course ( www.tmscourse.eu ) and received equipment support from MagVenture, MagStim and Deymed. C.W. is a member of the scientific advisory board of Brightmind.AI GmbH and a shareholder of ALSIX GmbH, supplier of tailored MR hardware. P.K. is employed by Localite GmbH, manufacturer of TMS neuronavigation devices. M.K., C.M. and Y.T. are employees of MagVenture, suppliers of TMS-fMRI solutions. R.M.C. is an employee of Rogue Research Solutions, supplier of TMS neuronavigation devices.
References
Publication types
Grants and funding
- SUAG/093/G116768/RCUK | Medical Research Council (MRC)
- MC_PC_20046/RCUK | Medical Research Council (MRC)
- BB/S019170/1/RCUK | Biotechnology and Biological Sciences Research Council (BBSRC)
- 525127358/Deutsche Forschungsgemeinschaft (German Research Foundation)
- 525176435/Deutsche Forschungsgemeinschaft (German Research Foundation)
- ZIAMH002955/U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH)
- ZIAMH002955/U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH)
- Lise Meitner Excellence Funding/Max-Planck-Gesellschaft (Max Planck Society)
- ERC-2021-COG 101043747/EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council)
- R61 MH135428/MH/NIMH NIH HHS/United States
- R01 MH120811/MH/NIMH NIH HHS/United States
- R313-2019-622/Lundbeckfonden (Lundbeck Foundation)
- R244-2017-196/Lundbeckfonden (Lundbeck Foundation)
- 9068-00025B/Innovationsfonden (Innovation Fund Denmark)
- P33180/Austrian Science Fund (Fonds zur Förderung der Wissenschaftlichen Forschung)
- 612022/European Commission (EC)
LinkOut - more resources
Full Text Sources
